Ibrahim N. Muhsen (Ibrahim N Muhsen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Machine Learning

Hodgkin Lymphoma

Stem Cell Transplantation

Top Venues

Bone marrow transplantation

British journal of haematology

Annals of hematology

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Ibrahim N. Muhsen, Helen E Heslop
Time to optimize vaccination strategies in blood cancer patients. British journal of haematology 205 (2) (2024)
Ibrahim N. Muhsen, Helen E Heslop
Time to optimize vaccination strategies in blood cancer patients. British journal of haematology (2024)
Shahrukh K Hashmi, Ray C Powles, David Ma, Ibrahim N. Muhsen, Mahmoud Aljurf, Dietger Niederwieser, Daniel J Weisdorf, Mickey B C Koh, Hildegard Greinix
Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help? Annals of hematology (2023)
Brian D Friend, Ibrahim N. Muhsen, Shreeya Patel, LaQuisa C Hill, Premal D Lulla, Carlos Almeida Ramos, S Ravi Pingali, Rammurti T Kamble, Tami D John, Baheyeldin Salem, Saleh Bhar, Erin E Doherty, John Craddock, Ghadir Sasa, Mengfen Wu, Tao Wang, Caridad Martinez, Robert A Krance, Helen E Heslop, George Carrum
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone marrow transplantation 57 (4) (2022)
Ibrahim N. Muhsen, Shahrukh K. Hashmi
Utilizing machine learning in predictive modeling: what's next? Bone marrow transplantation 57 (5) (2022)
David H M Steffin, Ibrahim N. Muhsen, LaQuisa C Hill, Carlos Almeida Ramos, Nabil M Ahmed, Meenakshi Hegde, Nicholas Wang, Mengfen Wu, Stephen Gottschalk, Sarah B Whittle, Premal D Lulla, Maksim Mamonkin, Bilal Omer, Rayne H Rouce, Andras A Heczey, Leonid S Metelitsa, Bambi J Grilley, Catherine Robertson, Virginia Torrano, Natalia Lapteva, Adrian P Gee, Cliona M Rooney, Malcolm K Brenner, Helen E Heslop
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood 140 (1) (2022)
Syeda A. Mina, Ibrahim N. Muhsen, Ethan A. Burns, Humaira Sarfraz, Sai Ravi Pingali, Jiaqiong Xu, Shahrukh K. Hashmi
Post-Marketing Analysis of Peripheral Neuropathy Burden with New-Generation Proteasome Inhibitors Using the FDA Adverse Event Reporting System Turkish journal of haematology : official journal of Turkish Society of Haematology 38 (3) (2021)
Mostafa F Mohammed Saleh, Ahmed Kotb, Ghada E M Abdallah, Ibrahim N. Muhsen, Riad El Fakih, Mahmoud Aljurf
Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma. Current oncology (Toronto, Ont.) 28 (6) (2021)